Filed: 8/14/2024ACC: 0001420506-24-001528
📋 What this filing means
SILVERARC CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 70 equity positions with a total reported market value of $423.87M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
70
Positions
$423.87M
Total AUM (reported)
54.23M
Total Shares
Allocation by class
COM$313.78M74.0%
COM NEW$35.24M8.3%
CALL$17.78M4.2%
SPONSORED ADS$13.20M3.1%
SHS$10.06M2.4%
COM PAR $.01$9.38M2.2%
CL A COM$7.95M1.9%
Portfolio Concentration
Top 3$93.38M22.0%
4–10$111.97M26.4%
11–25$115.34M27.2%
Rest$103.17M24.3%
Top 3 weight
22.0%
Top 10 weight
48.4%
Voting Authority Distribution
Total shares with voting rights: 54.23M
Sole
Full voting authority
54.23M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole70
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings70
Rows:
MERUS N V
SOLEShares623.63K
TypeSH
Market value$36.90M
8.71%
Sole
623.63K
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares465.71K
TypeSH
Market value$35.33M
8.33%
Sole
465.71K
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares517.73K
TypeSH
Market value$21.15M
4.99%
Sole
517.73K
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares1.10M
TypeSH
Market value$18.49M
4.36%
Sole
1.10M
Shared
0.00
None
0.00
ERASCA INC
SOLEShares7.82M
TypeSH
Market value$18.45M
4.35%
Sole
7.82M
Shared
0.00
None
0.00
INSMED INC
SOLEShares250K
TypeSH
Market value$16.75M
3.95%
Sole
250K
Shared
0.00
None
0.00
MORPHIC HLDG INC
SOLEShares486.31K
TypeSH
Market value$16.57M
3.91%
Sole
486.31K
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
SOLEShares625.09K
TypeSH
Market value$14.66M
3.46%
Sole
625.09K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares374.91K
TypeSH
Market value$13.88M
3.27%
Sole
374.91K
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares192.34K
TypeSH
Market value$13.17M
3.11%
Sole
192.34K
Shared
0.00
None
0.00
POSEIDA THERAPEUTICS INC
SOLEShares3.61M
TypeSH
Market value$10.54M
2.49%
Sole
3.61M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares1.21M
TypeSH
Market value$10.17M
2.40%
Sole
1.21M
Shared
0.00
None
0.00
INSMED INC
SOLEShares140K
TypeSH
Market value$9.38M
2.21%
Sole
140K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares36K
TypeSH
Market value$8.75M
2.06%
Sole
36K
Shared
0.00
None
0.00
ELUTIA INC
SOLEShares1.60M
TypeSH
Market value$7.95M
1.88%
Sole
1.60M
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
SOLEShares172.49K
TypeSH
Market value$7.81M
1.84%
Sole
172.49K
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares1.08M
TypeSH
Market value$7.61M
1.79%
Sole
1.08M
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares370K
TypeSH
Market value$7.60M
1.79%
Sole
370K
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares184.66K
TypeSH
Market value$7.58M
1.79%
Sole
184.66K
Shared
0.00
None
0.00
C4 THERAPEUTICS INC
SOLEShares1.44M
TypeSH
Market value$6.67M
1.57%
Sole
1.44M
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares42K
TypeSH
Market value$6.64M
1.57%
Sole
42K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares560.88K
TypeSH
Market value$6.61M
1.56%
Sole
560.88K
Shared
0.00
None
0.00
VERACYTE INC
SOLEShares282.25K
TypeSH
Market value$6.12M
1.44%
Sole
282.25K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares455.80K
TypeSH
Market value$6.03M
1.42%
Sole
455.80K
Shared
0.00
None
0.00
OLEMA PHARMACEUTICALS INC
SOLEShares546.86K
TypeSH
Market value$5.92M
1.40%
Sole
546.86K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MERUS N VSOLE | COM | 623.63K | SH | $36.90M 8.71% | 623.63K | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 465.71K | SH | $35.33M 8.33% | 465.71K | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | COM | 517.73K | SH | $21.15M 4.99% | 517.73K | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 1.10M | SH | $18.49M 4.36% | 1.10M | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 7.82M | SH | $18.45M 4.35% | 7.82M | 0.00 | 0.00 |
INSMED INCSOLE | CALL | 250K | SH | $16.75M 3.95% | 250K | 0.00 | 0.00 |
MORPHIC HLDG INCSOLE | COM | 486.31K | SH | $16.57M 3.91% | 486.31K | 0.00 | 0.00 |
AKERO THERAPEUTICS INCSOLE | COM | 625.09K | SH | $14.66M 3.46% | 625.09K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 374.91K | SH | $13.88M 3.27% | 374.91K | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 192.34K | SH | $13.17M 3.11% | 192.34K | 0.00 | 0.00 |
POSEIDA THERAPEUTICS INCSOLE | COM | 3.61M | SH | $10.54M 2.49% | 3.61M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 1.21M | SH | $10.17M 2.40% | 1.21M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 140K | SH | $9.38M 2.21% | 140K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 36K | SH | $8.75M 2.06% | 36K | 0.00 | 0.00 |
ELUTIA INCSOLE | CL A COM | 1.60M | SH | $7.95M 1.88% | 1.60M | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSSOLE | COM NEW | 172.49K | SH | $7.81M 1.84% | 172.49K | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 1.08M | SH | $7.61M 1.79% | 1.08M | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 370K | SH | $7.60M 1.79% | 370K | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 184.66K | SH | $7.58M 1.79% | 184.66K | 0.00 | 0.00 |
C4 THERAPEUTICS INCSOLE | COM STK | 1.44M | SH | $6.67M 1.57% | 1.44M | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 42K | SH | $6.64M 1.57% | 42K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 560.88K | SH | $6.61M 1.56% | 560.88K | 0.00 | 0.00 |
VERACYTE INCSOLE | COM | 282.25K | SH | $6.12M 1.44% | 282.25K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 455.80K | SH | $6.03M 1.42% | 455.80K | 0.00 | 0.00 |
OLEMA PHARMACEUTICALS INCSOLE | COM | 546.86K | SH | $5.92M 1.40% | 546.86K | 0.00 | 0.00 |
Page 1 of 3